A novel study indicates promising avenues in an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study indicates the possibility of using small vesicles (or exosomes) secreted by immature red blood cells as a vaccine platform against malaria. The paper was published in the journal Scientific Reports.
At the IGTP TODAY
Germans Trias researchers lead an international clinical trial to halt the advance of multiple sclerosis using cell therapy
A team of researchers from the Germans Trias i Pujol Hospital and Institute on the Can Ruti Campus, have started a phase I trial to slow the progress of multiple sclerosis (MS) with a cell product that uses the patient's own cells and reprograms their immune system.
The Genomics and Transcriptomics of Synucleinopathies Group led by Dr Katrin Beyer has moved closer towards finding a definitive biomarker for dementia with Lewy bodies (DLB). Their most recent work has been patented and the latest results have been published in the Journal of Alzheimer's Disease. This is the next step following on from work on new experimental models, biomarkers in blood samples and sleep disorders in dementia patients described earlier this year on this website.
A study led by the Neuromuscular and Neuropediatric Research Group at the Germans Trias i Pujol Research Institute shows for the first time that carriers of McArdle's disease can also show symptoms.
Rice against HIV: a three-protein cocktail produced in seeds shows potent HIV neutralization in vitro
Researchers from University of Lleida-Agrotecnio, IrsiCaixa AIDS Research Institute and ICREA obtained for the first time three different anti-HIV proteins from a single transgenic rice plant and crude extracts from it averted HIV from entering in human cells in vitro. Rice components showed an enhancing effect, further helping to block HIV infectivity. Dr Julià Blanco, researcher from the Institut Germans Trias i Pujol at IrsiCaixa, where he leads the Cell Virology and Immunology group, participated in the study.
In June this year the new Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) started its normal working activities. Located at the highest point of the campus, the CMCiB is a centre promoted by the Germans Trias i Pujol Research Institute (IGTP) and dedicated to biomedical research and training. The centre is an important addition to scientific infrastructures in southern Europe and is the only one in Spain, it has been set up to become a reference in comparative medicine, bioimaging and computational models with a clear remit to promote alternative research models and methods
A paper published by the IGTP Kidney-affecting Research Group (REMAR) is in the top 100 most read cellular biology papers in Scientific Reports in 2017. The journal published around one thousand articles on cellular biology last year, making the ranking especially remarkable for this paper on which Dr Francesc Borràs is co-corresponding author. The paper is ranked at 54.
The IGTP has organized a morning with the charity Fundació Salut Alta from Badalona that got everybody sticking together! The result of the experiment was 55 balls of coloured slime and a lot of happy faces!
Since 2007 the Immunopathology Group led by Dr Eva Martínez-Cáceres and Dr Cristian Ramo Tello at the IGTP has been working to develop a new treatment for autoimmune diseases, in this case for multiple sclerosis. To help their work in this task, Dr Martinez Cáceres has coordinated a COST project, a European network of scientists working on similar problems; the project concluded in 2017 and has now published its scientific report.
The Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP is partnering with Mind the Byte to work on the characterization and binding analysis of an immunostimulant known to trigger T-cell activation, which is crucial for the initiation and regulation of the immune response.